HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2002
11601	11601 Tsuboi Y, Baker M, Hutton ML, Uitti RJ, Rascol O, et al. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17) NEUROLOGY. 2002 DEC 10; 59 (11): 1791-1793	8	12	5	8
11602	11602 Bonini NM Chaperoning brain degeneration PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 10; 99: 16407-16411	61	107	14	34
11603	11603 Sakahira H, Breuer P, Hayer-Hartl MK, Hartl FU Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 10; 99: 16412-16418	28	105	25	83
11604	11604 Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 10; 99: 16419-16426	25	121	15	79
11605	11605 de la Paz ML, Goldie K, Zurdo J, Lacroix E, Dobson CM, et al. De novo designed peptide-based amyloid fibrils PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 10; 99 (25): 16052-16057	12	187	4	32
11606	11606 Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, Rebeck GW Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted A beta levels JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48508-48513	6	81	5	60
11607	11607 Lee HJ, Lee SJ Characterization of cytoplasmic alpha-synuclein aggregates - Fibril formation is tightly linked to the inclusion-forming process in cells JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48976-48983	69	87	29	40
11608	11608 Gosavi N, Lee HJ, Lee JS, Patel S, Lee SJ Golgi fragmentation occurs in the cells with prefibrillar alpha- synuclein aggregates and precedes the formation of fibrillar inclusion JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48984-48992	87	99	28	43
11609	11609 Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, et al. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 49071-49076	123	123	25	35
11610	11610 Yamamoto H, Yamauchi E, Taniguchi H, Ono T, Miyamoto E Phosphorylation of microtubule-associated protein tau by Ca2+/calmodulin-dependent protein kinase II in its tubulin binding sites ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2002 DEC 15; 408 (2): 255-262	2	15	22	53
#	Date / Author / Journal	LCS	GCS	LCR	CR
11611	11611 Lee VM, Sechrist JW, Bronner-Fraser M, Nishi R Neuronal differentiation from postmitotic precursors in the ciliary ganglion DEVELOPMENTAL BIOLOGY. 2002 DEC 15; 252 (2): 312-323	0	4	4	47
11612	11612 Funchal C, Pelaez PD, Loureiro SO, Vivian L, Pessutto FDB, et al. alpha-Ketoisocaproic acid regulates phosphorylation of intermediate filaments in postnatal rat cortical slices through ionotropic glutamatergic receptors DEVELOPMENTAL BRAIN RESEARCH. 2002 DEC 15; 139 (2): 267-276	2	17	7	53
11613	11613 Buttini M, Yu GQ, Shockley K, Huang YD, Jones B, et al. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation JOURNAL OF NEUROSCIENCE. 2002 DEC 15; 22 (24): 10539-10548	15	92	12	108
11614	11614 King SR, Manna PR, Ishii T, Syapin PJ, Ginsberg SD, et al. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain JOURNAL OF NEUROSCIENCE. 2002 DEC 15; 22 (24): 10613-10620	3	86	1	51
11615	11615 Tomasiewicz HG, Flaherty DB, Soria JP, Wood JG Transgenic zebrafish model of neurodegeneration JOURNAL OF NEUROSCIENCE RESEARCH. 2002 DEC 15; 70 (6): 734-745	14	28	45	68
11616	11616 Schuchmann M, Galle PR, Kanzler S Apoptosis in disease MEDIZINISCHE KLINIK. 2002 DEC 15; 97 (12): 738-746	0	1	2	123
11617	11617 Dieni S, Rees S Distribution of brain-derived neurotrophic factor and TrkB receptor proteins in the fetal and postnatal hippocampus and cerebellum of the guinea pig JOURNAL OF COMPARATIVE NEUROLOGY. 2002 DEC 16; 454 (3): 229-240	0	20	4	65
11618	11618 Heiland S, Sartor K, Martin E, Bardenheuer HJ, Plaschke K In vivo monitoring of age-related changes in rat brain using quantitative diffusion magnetic resonance imaging and magnetic resonance relaxometry NEUROSCIENCE LETTERS. 2002 DEC 16; 334 (3): 157-160	0	13	2	15
11619	11619 Barghorn S, Mandelkow E Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments BIOCHEMISTRY. 2002 DEC 17; 41 (50): 14885-14896	72	99	40	57
11620	11620 O'Donnell N Intracellular glycosylation and development BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 2002 DEC 19; 1573 (3): 336-345	0	18	12	125
#	Date / Author / Journal	LCS	GCS	LCR	CR
11621	11621 Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, et al. Parkin protects against the toxicity associated with mutant alpha- synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons NEURON. 2002 DEC 19; 36 (6): 1007-1019	170	271	34	53
11622	11622 Modo M, Rezaie P, Heuschling P, Patel S, Male DK, et al. Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response BRAIN RESEARCH. 2002 DEC 20; 958 (1): 70-82	24	68	8	56
11623	11623 Yoshida H, Goedert M Molecular cloning and functional characterization of chicken brain tau: Isoforms with up to five tandem repeats BIOCHEMISTRY. 2002 DEC 24; 41 (51): 15203-15211	12	17	25	45
11624	11624 Giasson BI, Sampathu DM, Wilson CA, Vogelsberg-Ragaglia V, Mushynski WE, et al. The environmental toxin arsenite induces tau hyperphosphorylation BIOCHEMISTRY. 2002 DEC 24; 41 (51): 15376-15387	6	9	43	95
11625	11625 Burbaud P, Vital A, Rougier A, Bouillot S, Guehl D, et al. Minimal tissue damage after stimulation of the motor thalamus in a case of chorea-acanthocytosis NEUROLOGY. 2002 DEC 24; 59 (12): 1982-1984	8	25	2	10
11626	11626 Thakur AK, Wetzel R Mutational analysis of the structural organization of polyglutamine aggregates PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 24; 99 (26): 17014-17019	17	88	4	36
11627	11627 Martin-Ruiz C, Lawrence S, Piggott M, Kuryatov A, Lindstrom J, et al. Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression NEUROSCIENCE LETTERS. 2002 DEC 25; 335 (2): 134-138	3	14	5	23
11628	11628 Boccardi M, Pennanen C, Laakso MP, Testa C, Geroldi C, et al. Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease NEUROSCIENCE LETTERS. 2002 DEC 25; 335 (2): 139-143	6	20	2	22
11629	11629 da Costa CA, Paitel E, Vincent B, Checler F alpha-Synuclein lowers p53-dependent apoptotic response of neuronal cells - Abolishment by 6-hydroxydopamine and implication for Parkinson's disease JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 27; 277 (52): 50980-50984	34	50	22	42
11630	11630 van Roon-Mom WMC, Reid SJ, Jones AL, MacDonald ME, Faull RLM, et al. Insoluble TATA-binding protein accumulation in Huntington's disease cortex MOLECULAR BRAIN RESEARCH. 2002 DEC 30; 109 (1-2): 1-10	3	4	16	48
#	Date / Author / Journal	LCS	GCS	LCR	CR
11631	11631 Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, et al. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease MOLECULAR BRAIN RESEARCH. 2002 DEC 30; 109 (1-2): 45-55	32	18	34	64
11632	11632 Davidsson P, Sjogren M, Andreasen N, Lindbjer M, Nilsson CL, et al. Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins MOLECULAR BRAIN RESEARCH. 2002 DEC 30; 109 (1-2): 128-133	11	10	9	37
2003
11633	11633 Caner H, Can A, Erdogan B, Atalay B, Albayrak AH, et al. Early effects of mild brain trauma on the cytoskeletal proteins neurofilament(160) and MAP(2), and the preventive effects of mexilitine 12TH EUROPEAN CONGRESS OF NEUROSURGERY (EANS), PROCEEDINGS. 2003; : 653-658	0	0	3	8
11634	11634 Stopa B, Piekarska B, Konieczny L, Rybarska J, Spolnik P, et al. The structure and protein binding of amyloid-specific dye reagents ACTA BIOCHIMICA POLONICA. 2003; 50 (4): 1213-1227	9	25	2	68
11635	11635 Wakabayashi K, Takahashi H alpha-Synuclein, synphilin-1 and inclusion body formation in alpha- synucleinopathies ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION. 2003; 1251: 149-156	0	0	26	45
11636	11636 Tarji K, Mori F, Imaizumi T, Yoshida H, Takahashi H, et al. Expression of alpha- and beta-synucleins in cultured astrocytes and the effects of inflammatory cytokines ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION. 2003; 1251: 157-164	0	0	24	36
11637	11637 Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K Widespread expression of alpha-synuclein in neuronal cytoplasm and glial cells in the central and peripheral nervous systems in human ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION. 2003; 1251: 165-171	0	0	27	33
11638	11638 Tamo W, Imaizumi T, Tanji K, Yoshida H, Mori F, et al. Expression of alpha-synuclein in vascular endothelial and smooth muscle cells ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION. 2003; 1251: 173-179	0	0	13	21
11639	11639 Helfand SL, Rogina B From genes to aging in Drosophila ADVANCES IN GENETICS, VOL 49. 2003; 49: 67-109	0	12	3	113
11640	11640 Marchal SP, Shehi E, Fusi P, Tortora P, Lange R Hydrostatic pressure effects on the stability of ataxin-3 ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY II, PROCEEDINGS. 2003; : 73-77	0	0	3	15
#	Date / Author / Journal	LCS	GCS	LCR	CR
11641	11641 Youdim MBH What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease? ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 73-88	0	0	10	80
11642	11642 Jellinger KA General aspects of neurodegeneration ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 101-144	0	0	89	198
11643	11643 Bosboom JLW, Stoffers D, Wolters EC The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 185-195	0	3	3	62
11644	11644 Watts RL, Raiser CD, Stover NP, Cornfeldt ML, Schweikert AW, et al. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 215-227	0	0	5	48
11645	11645 Looi JCL, Sachdev PS Structural neuroimaging of the ageing brain AGEING BRAIN. 2003; : 49-62	0	0	5	46
11646	11646 Kwok JBJ, Schofield PR The molecular basis of Alzheimer's disease and frontotemporal dementia AGEING BRAIN. 2003; : 173-185	0	0	15	48
11647	11647 Brayne C Will we all dement if we live long enough? AGEING BRAIN. 2003; : 243-257	0	0	5	76
11648	11648 Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, et al. Limitations of current Parkinson's disease therapy ANNALS OF NEUROLOGY. 2003; 53: S3-S12	5	65	2	101
11649	11649 Warner TT, Schapira AHV Genetic and environmental factors in the cause of Parkinson's disease ANNALS OF NEUROLOGY. 2003; 53: S16-S23	31	80	20	99
11650	11650 Jenner P Oxidative stress in Parkinson's disease ANNALS OF NEUROLOGY. 2003; 53: S26-S36	92	349	7	167
#	Date / Author / Journal	LCS	GCS	LCR	CR
11651	11651 McNaught KS, Olanow CW Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease ANNALS OF NEUROLOGY. 2003; 53: S73-S84	37	77	48	94
11652	11652 Stocchi F, Olanow CW Neuroprotection in Parkinson's disease: Clinical trials ANNALS OF NEUROLOGY. 2003; 53: S87-S97	6	41	9	102
11653	11653 Kieburtz K Designing neuroprotection trials in Parkinson's disease ANNALS OF NEUROLOGY. 2003; 53: S100-S107	1	8	8	73
11654	11654 Kordower JH In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease ANNALS OF NEUROLOGY. 2003; 53: S120-S132	19	53	2	39
11655	11655 Isacson O, Bjorklund LM, Schumacher JM Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells ANNALS OF NEUROLOGY. 2003; 53: S135-S146	19	49	8	108
11656	11656 Kertesz A, Munoz DG, Hillis A Preferred terminology ANNALS OF NEUROLOGY. 2003; 54: S3-S6	12	14	4	23
11657	11657 Miller BL, Diehl J, Freedman M, Kertesz A, Mendez M, et al. International approaches to frontotemporal dementia diagnosis: From social cognition to neuropsychology ANNALS OF NEUROLOGY. 2003; 54: S7-S10	7	18	5	22
11658	11658 Mesulam MM, Grossman M, Hillis A, Kertesz A, Weintraub S The core and halo of primary progressive aphasia and semantic dementia ANNALS OF NEUROLOGY. 2003; 54: S11-S14	23	45	8	38
11659	11659 Strong MJ, Lomen-Hoerth C, Caselli RJ, Bigio EH, Yang W Cognitive impairment, frontotemporal dementia, and the motor neuron diseases ANNALS OF NEUROLOGY. 2003; 54: S20-S23	18	31	10	43
11660	11660 Munoz DG, Dickson DW, Bergeron C, Mackenzie IRA, Delacourte A, et al. The neuropathology and biochemistry of frontotemporal dementia ANNALS OF NEUROLOGY. 2003; 54: S24-S28	37	40	14	25
#	Date / Author / Journal	LCS	GCS	LCR	CR
11661	11661 Bird T, Knopman D, VanSwieten J, Rosso S, Feldman H, et al. Epidemioloo and genetics of frontotemporal dementia/Pick's disease ANNALS OF NEUROLOGY. 2003; 54: S29-S31	29	36	9	19
11662	11662 Pasquier F, Fukui T, Sarazin M, Pijnenburg Y, Diehl J, et al. Laboratory investigations and treatment in frontotemporal dementia ANNALS OF NEUROLOGY. 2003; 54: S32-S35	6	7	5	26
11663	11663 Kang UJ, Nakamura K Potential of gene therapy for pediatric neurotransmitter diseases - Lessons from Parkinson's disease ANNALS OF NEUROLOGY. 2003; 54: S103-S109	1	2	7	75
11664	11664 Mayeux R Epidemiology of neurodegeneration ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 81-104	28	132	26	172
11665	11665 Caughey B, Lansbury PT Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 267-298	165	586	42	199
11666	11666 Bonini NM, Fortini ME Human neurodegenerative disease modeling using Drosophila ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 627-656	26	66	58	178
11667	11667 Murthy VN, De Camilli P Cell biology of the presynaptic terminal ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 701-728	12	163	2	210
11668	11668 Kagan J Biology, context, and developmental inquiry ANNUAL REVIEW OF PSYCHOLOGY. 2003; 54: 1-23	0	29	2	55
11669	11669 Pope SK, Shue VM, Beck C Will a healthy lifestyle help prevent Alzheimer's disease? ANNUAL REVIEW OF PUBLIC HEALTH. 2003; 24: 111-132	5	42	7	94
11670	11670 Delobel P, Mailliot C, Hamdane M, Sambo AV, Begard S, et al. Stable-tau overexpression in human neuroblastoma cells - An open door for explaining neuronal death in Tauopathies APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS. 2003; 1010: 623-634	5	8	20	28
#	Date / Author / Journal	LCS	GCS	LCR	CR
11671	11671 Hunkeler D, Rajotte R, Grey D, Morel P, Skjak-Break G, et al. Bioartificial organ grafts: A view at the beginning of the third millennium ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY. 2003; 31 (4): 365-382	0	3	1	56
11672	11672 Lev-Wiesel R, Hirshenzon-Segev E Alzheimer's disease as reflected in self-figure drawings of diagnosed patients ARTS IN PSYCHOTHERAPY. 2003; 30 (2): 83-89	0	1	1	24
11673	11673 Rodrigues CMP, Steer CJ Tauroursodeoxycholic acid for the treatment of acute and chronic neurodegenerative diseases BILE ACIDS: FROM GENOMICS TO DISEASE AND THERAPY. 2003; 129: 270-286	0	2	7	114
11674	11674 Neumnaitis J Selective replicating viral vectors - Potential for use in cancer gene therapy BIODRUGS. 2003; 17 (4): 251-262	0	1	14	217
11675	11675 Kaneuchi T, Togawa T, Matsuo T, Fuyama Y, Aigaki T Efficient measurement of H2O2 resistance in Drosophila using an activity monitor BIOGERONTOLOGY. 2003; 4 (3): 157-165	1	5	3	21
11676	11676 Thomas H, Lopez V Comparative study of inter-and intrahemispheric cortico-cortical connections in gerbil auditory cortex BIOLOGICAL RESEARCH. 2003; 36 (2): 155-169	0	1	2	30
11677	11677 Pradat PF, Mallet J Gene transfer into the central and peripheral nervous system: Applications for the treatment of neurodegenerative diseases and peripheral neuropathies BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL 20. 2003; 20: 49-76	0	1	18	238
11678	11678 Hoshino S, Inoue K, Yokoyama T, Kobayashi S, Asakura T, et al. Prions prevent brain damage after experimental brain injury: a preliminary report BRAIN EDEMA XII. 2003; 86: 297-299	1	22	1	17
11679	11679 Good CD Dementia and ageing BRITISH MEDICAL BULLETIN. 2003; 65: 159-+	0	5	1	38
11680	11680 Gambetti P, Kong QZ, Zou WQ, Parchi P, Chen SG Sporadic and familial CJD: classification and characterisation BRITISH MEDICAL BULLETIN. 2003; 66: 213-+	45	124	20	114
#	Date / Author / Journal	LCS	GCS	LCR	CR
11681	11681 Wadsworth JD, Hill AF, Beck JA, Collinge J Molecular and clinical classification of human prion disease BRITISH MEDICAL BULLETIN. 2003; 66: 241-254	14	43	7	64
11682	11682 Vidailhet M Parkinson's disease is an heterogeneous disorder BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE. 2003; 187 (2): 259-275	0	1	21	81
11683	11683 Duyckaerts C, Hauw JJ The Lewy body: an inadequate marker of Parkinson's disease ? BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE. 2003; 187 (2): 277-292	2	5	31	85
11684	11684 Borlongan CV, Sumaya I, Moss D, Kumazaki M, Sakurai T, et al. Melatonin-secreting pineal gland: A novel tissue source for neural transplantation therapy in stroke CELL TRANSPLANTATION. 2003; 12 (3): 225-234	5	11	10	58
11685	11685 Leary MC, Saver JL Annual incidence of first silent stroke in the United States: A preliminary estimate CEREBROVASCULAR DISEASES. 2003; 16 (3): 280-285	2	54	7	35
11686	11686 Martoncikova M, Orendacova J, Racekova E Clinical importance of testing olfactory functions for early detection of neurodegenerative diseases CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE. 2003; 66 (1): 3-7	0	3	5	47
11687	11687 Janus C Vaccines for Alzheimer's disease - How close are we? CNS DRUGS. 2003; 17 (7): 457-474	6	20	18	113
11688	11688 Festoff BW, Suo ZM, Citron BA Prospects for the pharmacotherapy of amyotrophic lateral sclerosis - Old strategies and new paradigms for the third millennium CNS DRUGS. 2003; 17 (10): 699-717	1	11	51	205
11689	11689 Mandel S, Grunblatt E, Riederer P, Gerlach M, Levites Y, et al. Neuroprotective strategies in Parkinson's disease - An update on progress CNS DRUGS. 2003; 17 (10): 729-762	10	98	17	335
11690	11690 Rosser AE, Dunnett SB Neural transplantation in patients with Huntington's disease CNS DRUGS. 2003; 17 (12): 853-867	4	22	8	110
#	Date / Author / Journal	LCS	GCS	LCR	CR
11691	11691 McCallion AS, Emison ES, Kashuk CS, Bush RT, Kenton M, et al. Genomic variation in multigenic traits: Hirschsprung disease COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY. 2003; 68: 373-381	0	12	1	34
11692	11692 Chiba-Falek O, Nussbaum RL Regulation of alpha-synuclein expression: Implications for Parkinson's disease COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY. 2003; 68: 409-415	5	6	31	56
11693	11693 Gabelli C Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditions CURRENT MEDICAL RESEARCH AND OPINION. 2003; 19 (2): 69-82	1	10	1	46
11694	11694 Abuljadayel HS Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood CURRENT MEDICAL RESEARCH AND OPINION. 2003; 19 (5): 355-375	0	0	1	64
11695	11695 de Paulis T The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D-2 receptors in human brain CURRENT PHARMACEUTICAL DESIGN. 2003; 9 (8): 673-696	1	30	1	168
11696	11696 Avramut M, Achim CL Immunophilins in nervous system degeneration and regeneration CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2003; 3 (12): 1376-1382	3	35	7	62
11697	11697 Grote SK, La Spada AR Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model CYTOGENETIC AND GENOME RESEARCH. 2003; 100 (1-4): 164-174	1	4	25	82
11698	11698 Kobayashi T, Kakizuka A Molecular analyses of Machado-Joseph disease CYTOGENETIC AND GENOME RESEARCH. 2003; 100 (1-4): 261-275	7	17	16	83
11699	11699 Odawara T, Iseki E, Kanai A, Arai T, Katsuragi T, et al. Clinicopathological study of two subtypes of Pick's disease in Japan DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 15 (1): 19-25	8	11	11	29
11700	11700 Tabet N, Walker Z, Mantel D, Costa D, Orrell M In vivo dopamine pre-synaptic receptors and antioxidant activities in patients with Alzheimer's disease, dementia with Lewy bodies and in controls - A preliminary report DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (1): 46-51	1	8	3	33

Date / Author / Journal

LCS

GCS

LCR

2002

11601

11601 Tsuboi Y, Baker M, Hutton ML, Uitti RJ, Rascol O, et al.

Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)

NEUROLOGY. 2002 DEC 10; 59 (11): 1791-1793

11602

11602 Bonini NM

Chaperoning brain degeneration

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 10; 99: 16407-16411

107

11603

11603 Sakahira H, Breuer P, Hayer-Hartl MK, Hartl FU

Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 10; 99: 16412-16418

105

11604

11604 Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, et al.

Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 10; 99: 16419-16426

121

11605

11605 de la Paz ML, Goldie K, Zurdo J, Lacroix E, Dobson CM, et al.

De novo designed peptide-based amyloid fibrils

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 10; 99 (25): 16052-16057

187

11606

11606 Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, Rebeck GW

Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted A beta levels

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48508-48513

11607

11607 Lee HJ, Lee SJ

Characterization of cytoplasmic alpha-synuclein aggregates - Fibril formation is tightly linked to the inclusion-forming process in cells

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48976-48983

11608

11608 Gosavi N, Lee HJ, Lee JS, Patel S, Lee SJ

Golgi fragmentation occurs in the cells with prefibrillar alpha- synuclein aggregates and precedes the formation of fibrillar inclusion

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48984-48992

11609

11609 Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, et al.

Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 49071-49076

123

11610

11610 Yamamoto H, Yamauchi E, Taniguchi H, Ono T, Miyamoto E

Phosphorylation of microtubule-associated protein tau by Ca2+/calmodulin-dependent protein kinase II in its tubulin binding sites

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2002 DEC 15; 408 (2): 255-262

Date / Author / Journal

LCS

GCS

LCR

11611

11611 Lee VM, Sechrist JW, Bronner-Fraser M, Nishi R

Neuronal differentiation from postmitotic precursors in the ciliary ganglion

DEVELOPMENTAL BIOLOGY. 2002 DEC 15; 252 (2): 312-323

11612

11612 Funchal C, Pelaez PD, Loureiro SO, Vivian L, Pessutto FDB, et al.

alpha-Ketoisocaproic acid regulates phosphorylation of intermediate filaments in postnatal rat cortical slices through ionotropic glutamatergic receptors

DEVELOPMENTAL BRAIN RESEARCH. 2002 DEC 15; 139 (2): 267-276

11613

11613 Buttini M, Yu GQ, Shockley K, Huang YD, Jones B, et al.

Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation

JOURNAL OF NEUROSCIENCE. 2002 DEC 15; 22 (24): 10539-10548

108

11614

11614 King SR, Manna PR, Ishii T, Syapin PJ, Ginsberg SD, et al.

An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain

JOURNAL OF NEUROSCIENCE. 2002 DEC 15; 22 (24): 10613-10620

11615

11615 Tomasiewicz HG, Flaherty DB, Soria JP, Wood JG

Transgenic zebrafish model of neurodegeneration

JOURNAL OF NEUROSCIENCE RESEARCH. 2002 DEC 15; 70 (6): 734-745

11616

11616 Schuchmann M, Galle PR, Kanzler S

Apoptosis in disease

MEDIZINISCHE KLINIK. 2002 DEC 15; 97 (12): 738-746

123

11617

11617 Dieni S, Rees S

Distribution of brain-derived neurotrophic factor and TrkB receptor proteins in the fetal and postnatal hippocampus and cerebellum of the guinea pig

JOURNAL OF COMPARATIVE NEUROLOGY. 2002 DEC 16; 454 (3): 229-240

11618

11618 Heiland S, Sartor K, Martin E, Bardenheuer HJ, Plaschke K

In vivo monitoring of age-related changes in rat brain using quantitative diffusion magnetic resonance imaging and magnetic resonance relaxometry

NEUROSCIENCE LETTERS. 2002 DEC 16; 334 (3): 157-160

11619

11619 Barghorn S, Mandelkow E

Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments

BIOCHEMISTRY. 2002 DEC 17; 41 (50): 14885-14896

11620

11620 O'Donnell N

Intracellular glycosylation and development

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 2002 DEC 19; 1573 (3): 336-345

125

Date / Author / Journal

LCS

GCS

LCR

11621

11621 Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, et al.

Parkin protects against the toxicity associated with mutant alpha- synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons

NEURON. 2002 DEC 19; 36 (6): 1007-1019

170

271

11622

11622 Modo M, Rezaie P, Heuschling P, Patel S, Male DK, et al.

Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response

BRAIN RESEARCH. 2002 DEC 20; 958 (1): 70-82

11623

11623 Yoshida H, Goedert M

Molecular cloning and functional characterization of chicken brain tau: Isoforms with up to five tandem repeats

BIOCHEMISTRY. 2002 DEC 24; 41 (51): 15203-15211

11624

11624 Giasson BI, Sampathu DM, Wilson CA, Vogelsberg-Ragaglia V, Mushynski WE, et al.

The environmental toxin arsenite induces tau hyperphosphorylation

BIOCHEMISTRY. 2002 DEC 24; 41 (51): 15376-15387

11625

11625 Burbaud P, Vital A, Rougier A, Bouillot S, Guehl D, et al.

Minimal tissue damage after stimulation of the motor thalamus in a case of chorea-acanthocytosis

NEUROLOGY. 2002 DEC 24; 59 (12): 1982-1984

11626

11626 Thakur AK, Wetzel R

Mutational analysis of the structural organization of polyglutamine aggregates

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 DEC 24; 99 (26): 17014-17019

11627

11627 Martin-Ruiz C, Lawrence S, Piggott M, Kuryatov A, Lindstrom J, et al.

Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression

NEUROSCIENCE LETTERS. 2002 DEC 25; 335 (2): 134-138

11628

11628 Boccardi M, Pennanen C, Laakso MP, Testa C, Geroldi C, et al.

Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease

NEUROSCIENCE LETTERS. 2002 DEC 25; 335 (2): 139-143

11629

11629 da Costa CA, Paitel E, Vincent B, Checler F

alpha-Synuclein lowers p53-dependent apoptotic response of neuronal cells - Abolishment by 6-hydroxydopamine and implication for Parkinson's disease

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 27; 277 (52): 50980-50984

11630

11630 van Roon-Mom WMC, Reid SJ, Jones AL, MacDonald ME, Faull RLM, et al.

Insoluble TATA-binding protein accumulation in Huntington's disease cortex

MOLECULAR BRAIN RESEARCH. 2002 DEC 30; 109 (1-2): 1-10

Date / Author / Journal

LCS

GCS

LCR

11631

11631 Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, et al.

Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease

MOLECULAR BRAIN RESEARCH. 2002 DEC 30; 109 (1-2): 45-55

11632

11632 Davidsson P, Sjogren M, Andreasen N, Lindbjer M, Nilsson CL, et al.

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

MOLECULAR BRAIN RESEARCH. 2002 DEC 30; 109 (1-2): 128-133

2003

11633

11633 Caner H, Can A, Erdogan B, Atalay B, Albayrak AH, et al.

Early effects of mild brain trauma on the cytoskeletal proteins neurofilament(160) and MAP(2), and the preventive effects of mexilitine

12TH EUROPEAN CONGRESS OF NEUROSURGERY (EANS), PROCEEDINGS. 2003; : 653-658

11634

11634 Stopa B, Piekarska B, Konieczny L, Rybarska J, Spolnik P, et al.

The structure and protein binding of amyloid-specific dye reagents

ACTA BIOCHIMICA POLONICA. 2003; 50 (4): 1213-1227

11635

11635 Wakabayashi K, Takahashi H

alpha-Synuclein, synphilin-1 and inclusion body formation in alpha- synucleinopathies

ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION. 2003; 1251: 149-156

11636

11636 Tarji K, Mori F, Imaizumi T, Yoshida H, Takahashi H, et al.

Expression of alpha- and beta-synucleins in cultured astrocytes and the effects of inflammatory cytokines

ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION. 2003; 1251: 157-164

11637

11637 Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K

Widespread expression of alpha-synuclein in neuronal cytoplasm and glial cells in the central and peripheral nervous systems in human

ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION. 2003; 1251: 165-171

11638

11638 Tamo W, Imaizumi T, Tanji K, Yoshida H, Mori F, et al.

Expression of alpha-synuclein in vascular endothelial and smooth muscle cells

ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION. 2003; 1251: 173-179

11639

11639 Helfand SL, Rogina B

From genes to aging in Drosophila

ADVANCES IN GENETICS, VOL 49. 2003; 49: 67-109

113

11640

11640 Marchal SP, Shehi E, Fusi P, Tortora P, Lange R

Hydrostatic pressure effects on the stability of ataxin-3

ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY II, PROCEEDINGS. 2003; : 73-77

Date / Author / Journal

11641

What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?

ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 73-88

11642

11642 Jellinger KA

General aspects of neurodegeneration

ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 101-144

198

11643

11643 Bosboom JLW, Stoffers D, Wolters EC

The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease

ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 185-195

11644

11644 Watts RL, Raiser CD, Stover NP, Cornfeldt ML, Schweikert AW, et al.

Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease

ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 215-227

11645

11645 Looi JCL, Sachdev PS

Structural neuroimaging of the ageing brain

AGEING BRAIN. 2003; : 49-62

11646

11646 Kwok JBJ, Schofield PR

The molecular basis of Alzheimer's disease and frontotemporal dementia

AGEING BRAIN. 2003; : 173-185

11647

11647 Brayne C

Will we all dement if we live long enough?

AGEING BRAIN. 2003; : 243-257

11648

11648 Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, et al.

Limitations of current Parkinson's disease therapy

ANNALS OF NEUROLOGY. 2003; 53: S3-S12

101

11649

11649 Warner TT, Schapira AHV

Genetic and environmental factors in the cause of Parkinson's disease

ANNALS OF NEUROLOGY. 2003; 53: S16-S23

11650

11650 Jenner P

Oxidative stress in Parkinson's disease

ANNALS OF NEUROLOGY. 2003; 53: S26-S36

349

167

Date / Author / Journal

LCS

GCS

LCR

11651

11651 McNaught KS, Olanow CW

Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease

ANNALS OF NEUROLOGY. 2003; 53: S73-S84

11652

11652 Stocchi F, Olanow CW

Neuroprotection in Parkinson's disease: Clinical trials

ANNALS OF NEUROLOGY. 2003; 53: S87-S97

102

11653

11653 Kieburtz K

Designing neuroprotection trials in Parkinson's disease

ANNALS OF NEUROLOGY. 2003; 53: S100-S107

11654

11654 Kordower JH

In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease

ANNALS OF NEUROLOGY. 2003; 53: S120-S132

11655

11655 Isacson O, Bjorklund LM, Schumacher JM

Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells

ANNALS OF NEUROLOGY. 2003; 53: S135-S146

108

11656

11656 Kertesz A, Munoz DG, Hillis A

Preferred terminology

ANNALS OF NEUROLOGY. 2003; 54: S3-S6

11657

11657 Miller BL, Diehl J, Freedman M, Kertesz A, Mendez M, et al.

International approaches to frontotemporal dementia diagnosis: From social cognition to neuropsychology

ANNALS OF NEUROLOGY. 2003; 54: S7-S10

11658

11658 Mesulam MM, Grossman M, Hillis A, Kertesz A, Weintraub S

The core and halo of primary progressive aphasia and semantic dementia

ANNALS OF NEUROLOGY. 2003; 54: S11-S14

11659

11659 Strong MJ, Lomen-Hoerth C, Caselli RJ, Bigio EH, Yang W

Cognitive impairment, frontotemporal dementia, and the motor neuron diseases

ANNALS OF NEUROLOGY. 2003; 54: S20-S23

11660

11660 Munoz DG, Dickson DW, Bergeron C, Mackenzie IRA, Delacourte A, et al.

The neuropathology and biochemistry of frontotemporal dementia

ANNALS OF NEUROLOGY. 2003; 54: S24-S28

Date / Author / Journal

LCS

GCS

LCR

11661

11661 Bird T, Knopman D, VanSwieten J, Rosso S, Feldman H, et al.

Epidemioloo and genetics of frontotemporal dementia/Pick's disease

ANNALS OF NEUROLOGY. 2003; 54: S29-S31

11662

11662 Pasquier F, Fukui T, Sarazin M, Pijnenburg Y, Diehl J, et al.

Laboratory investigations and treatment in frontotemporal dementia

ANNALS OF NEUROLOGY. 2003; 54: S32-S35

11663

11663 Kang UJ, Nakamura K

Potential of gene therapy for pediatric neurotransmitter diseases - Lessons from Parkinson's disease

ANNALS OF NEUROLOGY. 2003; 54: S103-S109

11664

11664 Mayeux R

Epidemiology of neurodegeneration

ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 81-104

132

172

11665

11665 Caughey B, Lansbury PT

Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders

ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 267-298

165

586

199

11666

11666 Bonini NM, Fortini ME

Human neurodegenerative disease modeling using Drosophila

ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 627-656

178

11667

11667 Murthy VN, De Camilli P

Cell biology of the presynaptic terminal

ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 701-728

163

210

11668

11668 Kagan J

Biology, context, and developmental inquiry

ANNUAL REVIEW OF PSYCHOLOGY. 2003; 54: 1-23

11669

11669 Pope SK, Shue VM, Beck C

Will a healthy lifestyle help prevent Alzheimer's disease?

ANNUAL REVIEW OF PUBLIC HEALTH. 2003; 24: 111-132

11670

11670 Delobel P, Mailliot C, Hamdane M, Sambo AV, Begard S, et al.

Stable-tau overexpression in human neuroblastoma cells - An open door for explaining neuronal death in Tauopathies

APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS. 2003; 1010: 623-634

Date / Author / Journal

LCS

GCS

LCR

11671

11671 Hunkeler D, Rajotte R, Grey D, Morel P, Skjak-Break G, et al.

Bioartificial organ grafts: A view at the beginning of the third millennium

ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY. 2003; 31 (4): 365-382

11672

11672 Lev-Wiesel R, Hirshenzon-Segev E

Alzheimer's disease as reflected in self-figure drawings of diagnosed patients

ARTS IN PSYCHOTHERAPY. 2003; 30 (2): 83-89

11673

11673 Rodrigues CMP, Steer CJ

Tauroursodeoxycholic acid for the treatment of acute and chronic neurodegenerative diseases

BILE ACIDS: FROM GENOMICS TO DISEASE AND THERAPY. 2003; 129: 270-286

114

11674

11674 Neumnaitis J

Selective replicating viral vectors - Potential for use in cancer gene therapy

BIODRUGS. 2003; 17 (4): 251-262

217

11675

11675 Kaneuchi T, Togawa T, Matsuo T, Fuyama Y, Aigaki T

Efficient measurement of H2O2 resistance in Drosophila using an activity monitor

BIOGERONTOLOGY. 2003; 4 (3): 157-165

11676

11676 Thomas H, Lopez V

Comparative study of inter-and intrahemispheric cortico-cortical connections in gerbil auditory cortex

BIOLOGICAL RESEARCH. 2003; 36 (2): 155-169

11677

11677 Pradat PF, Mallet J

Gene transfer into the central and peripheral nervous system: Applications for the treatment of neurodegenerative diseases and peripheral neuropathies

BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL 20. 2003; 20: 49-76

238

11678

11678 Hoshino S, Inoue K, Yokoyama T, Kobayashi S, Asakura T, et al.

Prions prevent brain damage after experimental brain injury: a preliminary report

BRAIN EDEMA XII. 2003; 86: 297-299

11679

11679 Good CD

Dementia and ageing

BRITISH MEDICAL BULLETIN. 2003; 65: 159-+

11680

11680 Gambetti P, Kong QZ, Zou WQ, Parchi P, Chen SG

Sporadic and familial CJD: classification and characterisation

BRITISH MEDICAL BULLETIN. 2003; 66: 213-+

124

114

Date / Author / Journal

LCS

GCS

LCR

11681

11681 Wadsworth JD, Hill AF, Beck JA, Collinge J

Molecular and clinical classification of human prion disease

BRITISH MEDICAL BULLETIN. 2003; 66: 241-254

11682

11682 Vidailhet M

Parkinson's disease is an heterogeneous disorder

BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE. 2003; 187 (2): 259-275

11683

11683 Duyckaerts C, Hauw JJ

The Lewy body: an inadequate marker of Parkinson's disease ?

BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE. 2003; 187 (2): 277-292

11684

11684 Borlongan CV, Sumaya I, Moss D, Kumazaki M, Sakurai T, et al.

Melatonin-secreting pineal gland: A novel tissue source for neural transplantation therapy in stroke

CELL TRANSPLANTATION. 2003; 12 (3): 225-234

11685

11685 Leary MC, Saver JL

Annual incidence of first silent stroke in the United States: A preliminary estimate

CEREBROVASCULAR DISEASES. 2003; 16 (3): 280-285

11686

11686 Martoncikova M, Orendacova J, Racekova E

Clinical importance of testing olfactory functions for early detection of neurodegenerative diseases

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE. 2003; 66 (1): 3-7

11687

11687 Janus C

Vaccines for Alzheimer's disease - How close are we?

CNS DRUGS. 2003; 17 (7): 457-474

113

11688

11688 Festoff BW, Suo ZM, Citron BA

Prospects for the pharmacotherapy of amyotrophic lateral sclerosis - Old strategies and new paradigms for the third millennium

CNS DRUGS. 2003; 17 (10): 699-717

205

11689

11689 Mandel S, Grunblatt E, Riederer P, Gerlach M, Levites Y, et al.

Neuroprotective strategies in Parkinson's disease - An update on progress

CNS DRUGS. 2003; 17 (10): 729-762

335

11690

11690 Rosser AE, Dunnett SB

Neural transplantation in patients with Huntington's disease

CNS DRUGS. 2003; 17 (12): 853-867

110

Date / Author / Journal

LCS

GCS

LCR

11691

11691 McCallion AS, Emison ES, Kashuk CS, Bush RT, Kenton M, et al.

Genomic variation in multigenic traits: Hirschsprung disease

COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY. 2003; 68: 373-381

11692

11692 Chiba-Falek O, Nussbaum RL

Regulation of alpha-synuclein expression: Implications for Parkinson's disease

COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY. 2003; 68: 409-415

11693

11693 Gabelli C

Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditions

CURRENT MEDICAL RESEARCH AND OPINION. 2003; 19 (2): 69-82

11694

11694 Abuljadayel HS

Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood

CURRENT MEDICAL RESEARCH AND OPINION. 2003; 19 (5): 355-375

11695

11695 de Paulis T

The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D-2 receptors in human brain

CURRENT PHARMACEUTICAL DESIGN. 2003; 9 (8): 673-696

168

11696

11696 Avramut M, Achim CL

Immunophilins in nervous system degeneration and regeneration

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2003; 3 (12): 1376-1382

11697

11697 Grote SK, La Spada AR

Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model

CYTOGENETIC AND GENOME RESEARCH. 2003; 100 (1-4): 164-174

11698

11698 Kobayashi T, Kakizuka A

Molecular analyses of Machado-Joseph disease

CYTOGENETIC AND GENOME RESEARCH. 2003; 100 (1-4): 261-275

11699

11699 Odawara T, Iseki E, Kanai A, Arai T, Katsuragi T, et al.

Clinicopathological study of two subtypes of Pick's disease in Japan

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 15 (1): 19-25

11700

11700 Tabet N, Walker Z, Mantel D, Costa D, Orrell M

In vivo dopamine pre-synaptic receptors and antioxidant activities in patients with Alzheimer's disease, dementia with Lewy bodies and in controls - A preliminary report

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (1): 46-51

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records